Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

AdaptHealth Corp. (AHCO)

Nasdaq Health Care Health Care Equipment S&P SmallCap 600
$7.33
-0.08 (-1.08%)
Close of Nov 06, 2026 · end-of-day data
Source: AdaptHealth Corp.'s 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 04, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$345.28M$529.64M$1.06B$2.45B$2.97B$3.20B$3.26B$3.24B
Cost of revenue$293.38M$440.70M$898.60M$2.01B$2.39B$2.58B$2.58B$2.64B
Gross profit$51.89M$88.94M$157.79M$445.61M$580.12M$624.07M$681.09M$609.20M
Operating income$31.09M$29.38M$71.35M$225.60M$190.41M-$598.40M$263.73M$90.87M
Interest expense$7.45M$39.30M$41.43M$95.19M$109.41M$130.30M$124.70M$103.60M
Pre-tax income$22.24M-$21.86M-$206.04M$190.96M$97.90M-$723.78M$136.02M-$15.15M
Income tax-$2.10M$739.00K-$11.96M$32.81M$24.77M-$49.00M$41.24M$50.88M
Net income$23.26M-$21.34M-$161.63M$156.18M$69.32M-$678.89M$90.42M-$70.79M
EBITDA$78.97M$91.94M$153.79M$483.66M$541.59M-$215.62M$629.07M$472.80M
EPS (basic)$1.95$-0.95$-3.08$1.12$0.47$-5.06$0.62$-0.52
EPS (diluted)$1.95$-0.95$-3.08$0.67$0.33$-5.31$0.61$-0.52
Diluted shares11.90M22.56M52.49M133.03M138.99M134.42M135.53M135.15M
Gross margin15.0%16.8%14.9%18.2%19.5%19.5%20.9%18.8%
Operating margin9.0%5.5%6.8%9.2%6.4%-18.7%8.1%2.8%
Net margin6.7%-4.0%-15.3%6.4%2.3%-21.2%2.8%-2.2%

Balance sheet

fiscal years · USD
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$947.10K$76.88M$99.96M$149.63M$46.27M$77.13M$109.75M$106.14M
Receivables$53.02M$78.62M$171.06M$359.90M$359.15M$388.91M$408.02M$370.90M
Inventory$7.67M$13.24M$58.78M$123.09M$127.75M$113.64M$139.84M$114.89M
Total current assets$90.79M$181.41M$363.25M$670.06M$585.31M$649.02M$755.79M$728.90M
Goodwill$202.44M$266.79M$998.81M$3.51B$3.55B$2.72B$2.68B$2.46B
Total assets$368.96M$546.54M$1.81B$5.25B$5.22B$4.51B$4.49B$4.32B
Total current liabilities$135.68M$154.05M$422.05M$499.81M$456.21M$537.00M$566.99M$712.39M
Short-term debt$7.09M$1.72M$8.15M$20.00M$35.00M$53.37M$16.25M$20.31M
Long-term debt$127.09M$395.11M$776.57M$2.18B$2.15B$2.09B$1.96B$1.72B
Total debt$134.18M$396.83M$784.71M$2.20B$2.19B$2.15B$1.98B$1.74B
Total liabilities$266.19M$612.32M$1.53B$3.18B$3.06B$3.04B$2.91B$2.79B
Shareholders' equity$5.00M-$38.82M$354.89M$2.06B$2.15B$1.46B$1.57B$1.52B

Cash flow

fiscal years · USD
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$68.43M$60.42M$195.63M$275.68M$373.87M$480.67M$541.84M$601.77M
Capital expenditures$9.95M$21.33M$39.76M$203.31M$391.42M$337.46M$306.06M$382.39M
Free cash flow$58.48M$39.09M$155.88M$72.37M-$17.56M$143.20M$235.78M$219.38M
Investing cash flow-$96.28M-$84.87M-$815.70M-$1.82B-$411.17M-$357.28M-$310.27M-$303.19M
Financing cash flow$48.77M$76.14M$643.15M$1.60B-$66.05M-$92.53M-$198.95M-$302.19M
Share buybacks—$20.00M$0$0$13.99M$29.27M$0$0
Stock-based compensation$883.37K$11.07M$18.67M$25.32M$22.40M$22.47M$14.88M$21.88M
Depreciation & amortization$47.88M$62.57M$82.44M$258.05M$351.18M$382.78M$365.33M$381.93M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.